{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:23:24Z","timestamp":1787304204703,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2025\/28315\\u20132"],"award-info":[{"award-number":["2025\/28315\\u20132"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2014\/14202\\u20137"],"award-info":[{"award-number":["2014\/14202\\u20137"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2023\/12378\\u20130"],"award-info":[{"award-number":["2023\/12378\\u20130"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.taap.2026.117947","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:53:35Z","timestamp":1784044415000},"page":"117947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Histoprotective and antiproliferative effects of Raloxifene treatment during prostate carcinogenesis in rats"],"prefix":"10.1016","volume":"515","author":[{"given":"Cristiane Figueiredo","family":"Pinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liara Bot\u00e3o da Silva","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Landeira Gomez","family":"Chamelete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna Cassone","family":"Salata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana Musa de","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Teves Aquino Gon\u00e7alves de","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo de Oliveira","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellerson Rodrigo","family":"Scarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.taap.2026.117947_bb0005","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/pros.20719","article-title":"Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat","volume":"68","author":"Bernoulli","year":"2008","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.taap.2026.117947_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1158\/1541-7786.MCR-18-0522","article-title":"The aged microenvironment influences the tumorigenic potential of malignant prostate epithelial cells","volume":"17","author":"Bianchi-Frias","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.taap.2026.117947_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pros.23446","article-title":"Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression","volume":"78","author":"Bonkhoff","year":"2018","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.taap.2026.117947_bb0020","first-page":"700","volume":"50","author":"Bosland","year":"1990","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.taap.2026.117947_bb0025","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.taap.2026.117947_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0890-6238(98)00003-3","article-title":"The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing","volume":"12","author":"Buelke-Sam","year":"1998","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.taap.2026.117947_bb0035","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jcb.21529","article-title":"Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario","volume":"102","author":"Carruba","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.taap.2026.117947_bb0040","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846557","article-title":"Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1A and reduces cancer cell survival","volume":"20","author":"Cortes","year":"2019","journal-title":"EMBO Rep."},{"issue":"11","key":"10.1016\/j.taap.2026.117947_bb0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/cbin.10787","article-title":"Fibrillar collagen genes are not coordinately upregulated with TGF \u03b21 expression in finasteride-treated prostate","volume":"41","author":"Delella","year":"2017","journal-title":"Cell Biol. Int."},{"issue":"5","key":"10.1016\/j.taap.2026.117947_bb0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1590\/s1677-5538.ibju.2016.0484","article-title":"The prostate after castration and hormone replacement in a rat model: structural and ultrastructural analysis","volume":"43","author":"Felix-Patr\u00edcio","year":"2017","journal-title":"Int. Braz. J. Urol."},{"issue":"11","key":"10.1016\/j.taap.2026.117947_bb0055","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/pros.22669","article-title":"A new proposed rodent model of chemically induced prostate carcinogenesis: distinct time-course prostate cancer progression in the dorsolateral and ventral lobes","volume":"73","author":"Gon\u00e7alves","year":"2013","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.taap.2026.117947_bb0060","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/pros.23353","article-title":"Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: protective effect and emergence of unstable epithelial microenvironment","volume":"77","author":"Gon\u00e7alves","year":"2017","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.taap.2026.117947_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12672-018-0323-z","article-title":"Combinatorial effect of Abiraterone acetate and NVP-BEZ235 on prostate tumor progression in rats","volume":"9","author":"Gon\u00e7alves","year":"2018","journal-title":"Horm Cancer."},{"issue":"8","key":"10.1016\/j.taap.2026.117947_bb0070","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/1061186X.2019.1566341","article-title":"Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-\u03b2 and epidermal growth factor receptor","volume":"27","author":"Greish","year":"2019","journal-title":"J. Drug Target."},{"issue":"Suppl. 3","key":"10.1016\/j.taap.2026.117947_bb0075","first-page":"24","article-title":"Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer","volume":"32","author":"Griffiths","year":"1997","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.taap.2026.117947_bb0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.clgc.2016.08.026","article-title":"A study of combination Bicalutamide and Raloxifene for patients with castration-resistant prostate Cancer","volume":"15","author":"Ho","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"issue":"2","key":"10.1016\/j.taap.2026.117947_bb0085","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2353\/ajpath.2010.100070","article-title":"Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy","volume":"177","author":"Johansson","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.taap.2026.117947_bb0090","first-page":"3649","article-title":"Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway","volume":"62","author":"Kim","year":"2002","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.taap.2026.117947_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170809","article-title":"The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression","volume":"134","author":"Lafront","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.taap.2026.117947_bb0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2008.05.003","article-title":"Cancer and inflammation: a complex relationship","volume":"267","author":"Mantovani","year":"2008","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.taap.2026.117947_bb0105","first-page":"3282","article-title":"Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats","volume":"58","author":"McCormick","year":"1998","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.taap.2026.117947_bb0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pros.2990230307","article-title":"Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat","volume":"23","author":"Neubauer","year":"1993","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.taap.2026.117947_bb0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/pros.2990270407","article-title":"Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model","volume":"27","author":"Neubauer","year":"1995","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.taap.2026.117947_bb0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3390\/biomedicines10040853","article-title":"Raloxifene suppresses tumor growth and metastasis in an Orthotopic model of castration-resistant prostate Cancer","volume":"10","author":"Palmer","year":"2022","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.taap.2026.117947_bb0125","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/tox.22126","article-title":"Gestational and lactational exposition to Di-N-butyl-phthalate (DBP) increases inflammation and preneoplastic lesions in prostate of wistar rats after carcinogenic N-methyl-N-nitrosourea (MNU) plus testosterone protocol","volume":"31","author":"Peixoto","year":"2016","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.taap.2026.117947_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.phrs.2013.10.002","article-title":"Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells","volume":"79","author":"Piccolella","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.taap.2026.117947_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/1061186X.2015.1086360","article-title":"Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer","volume":"24","author":"Pritchard","year":"2016","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.taap.2026.117947_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-4-38","article-title":"Collagen reorganization at the tumor-stromal interface facilitates local invasion","volume":"4","author":"Provenzano","year":"2006","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.taap.2026.117947_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00306176","article-title":"Methacarn (methanol-Carnoy) fixation. Practical and theoretical considerations","volume":"21","author":"Puchtler","year":"1970","journal-title":"Histochemie"},{"key":"10.1016\/j.taap.2026.117947_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2023.1207612","article-title":"Exposure to Dichlorvos pesticide alters the morphology of and lipid metabolism in the ventral prostate of rats","volume":"5","author":"Quintino-Ottonicar","year":"2023","journal-title":"Front Toxicol."},{"issue":"7","key":"10.1016\/j.taap.2026.117947_bb0155","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/jphp.13089","article-title":"Raloxifene decreases cell viability and migratory potential in prostate cancer cells (LNCaP) with GPR30\/GPER1 involvement","volume":"71","author":"Salata","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2026.117947_bb0160","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-03-0946","article-title":"Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the mouse models of human Cancer consortium prostate pathology committee","volume":"64","author":"Shappell","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.taap.2026.117947_bb0165","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-410X.2006.05974.x","article-title":"Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial","volume":"97","author":"Shazer","year":"2006","journal-title":"BJU Int."},{"issue":"Suppl 3(Suppl 3)","key":"10.1016\/j.taap.2026.117947_bb0170","first-page":"S30","article-title":"Selective estrogen receptor modulators to prevent treatment-related osteoporosis","volume":"7","author":"Smith","year":"2005","journal-title":"Rev. Urol."},{"issue":"20 Pt 2","key":"10.1016\/j.taap.2026.117947_bb0175","doi-asserted-by":"crossref","first-page":"6315s","DOI":"10.1158\/1078-0432.CCR-06-0846","article-title":"Treatment-related osteoporosis in men with prostate cancer","volume":"12","author":"Smith","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2026.117947_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/323594","article-title":"A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer","volume":"2014","author":"Taurin","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.taap.2026.117947_bb0185","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.eururo.2024.08.030","article-title":"Radical prostatectomy versus stereotactic radiotherapy for clinically localised prostate Cancer: results of the PACE-A randomised trial","volume":"86","author":"van As","year":"2024","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.taap.2026.117947_bb0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrurol.2016.89","article-title":"The role of the prostate in male fertility, health and disease","volume":"13","author":"Verze","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.taap.2026.117947_bb0195","first-page":"131","article-title":"Principles and methods for the morphometric study of the lung and other organs","volume":"12","author":"Weibel","year":"1978","journal-title":"Lab. Investig."},{"issue":"5","key":"10.1016\/j.taap.2026.117947_bb0200","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/aja.2010.24","article-title":"Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia","volume":"12","author":"Yang","year":"2010","journal-title":"Asian J. Androl."},{"issue":"6","key":"10.1016\/j.taap.2026.117947_bb0205","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/carcin\/bgi056","article-title":"Inhibition of prostate carcinogenesis in probasin\/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor","volume":"26","author":"Zeng","year":"2005","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.taap.2026.117947_bb0210","first-page":"271","article-title":"The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment","volume":"88","author":"Zhang","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:26:32Z","timestamp":1787300792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26002437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0041008X26002437"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117947","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histoprotective and antiproliferative effects of Raloxifene treatment during prostate carcinogenesis in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117947"}}